Astera Labs, Inc. (ALAB) intrinsic value & 10-year financials
Astera Labs, Inc. (ALAB) has a Graham intrinsic value of $40.52 per share. At $285.82 on Oct 17, 2026, the stock trades 605% above that value. Over the last 5 fiscal years revenue grew 120.2% a year to $852.5M, with an average return on invested capital of 25.6%.
- Graham intrinsic value
- $40.52
- Share price (Oct 17, 2026)
- $285.82
- Price vs Graham value
- 605% above
- Market cap
- $51.3B
- Revenue (FY2025)
- $852.5M
- Revenue growth (5-yr CAGR)
- 120.2%
- ROIC (10-yr avg)
- 25.6%
- Free cash flow (FY2025)
- $281.8M
ALAB 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $852.5M | $219.1M | $1.22 | $281.8M | 20.3% | 16.4% |
| FY2024 | $396.3M | -$83.4M | -$0.64 | $102.4M | -29.3% | -31.2% |
| FY2023 | $115.8M | -$26.3M | -$0.71 | -$15.5M | -25.5% | 20.8% |
| FY2022 | $79.9M | -$58.3M | -$1.71 | -$39.8M | -75.4% | 96.3% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Astera Labs, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Astera Labs, Inc. has historically struggled to out-earn its cost of capital, averaging just 2.0% ROIC.
Astera Labs, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Astera Labs, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $40.52 per share.